Randomised controlled trialindependent cross-checkabstract checked★ key study I-EGG-105 in-depth review

One egg a day helped babies in Ecuador grow

Eggs in Early Complementary Feeding and Child Growth: A Randomized Controlled Trial.

Overview

Iannotti LL et al.. Pediatrics 2017 · PMID 28588101 · DOI 10.1542/peds.2016-3459

Babies given an egg daily for 6 months had less stunting (PR 0.53) and no reported allergic reactions.

Does the study support the specific claim? No · Methodological quality: moderate

Original publication

Plain-language summary

Study explained simply
What did the researchers want to find out?

Test eggs for child growth.

How was the study done?

Randomized trial.

How many people, animals or samples were studied?

163 infants aged 6-9 months.

What was actually found?

Better length and weight; less stunting.

How large was the observed effect?

LAZ +0.63; stunting -47%.

What do the results mean in everyday life?

Eggs can be a safe and useful food for babies.

What are the study's limitations?

Small, unblinded; not replicated in Malawi.

What does it say about Elawady's specific claim?

Contradicts the idea that eggs are harmful for children.

Do the results apply to Germany and Europe?

Limited (different nutrition context).

What can explicitly not be concluded from this study?

It cannot prove eggs improve growth everywhere.

Scientific in-depth review

1. Full reference

Authors
Iannotti LL et al.
Journal
Pediatrics
Year
2017
Identifier
PMID 28588101 DOI 10.1542/peds.2016-3459
Verification
verified – PubMed efetch 2026-10-26; Crossref works API 2026-10-26
Retracted
no
Corrections
none
Extent checked
abstract only
Conflicts of interest and funding

Funded by The Mathile Institute (not-for-profit); two authors worked for the funder.

2. Research question

Does introducing one egg per day early in complementary feeding improve child growth?

3. Study design and population

Study design
Randomised controlled trial – Randomized controlled trial (Lulun Project), 6 months
Population

Children aged 6-9 months, Cotopaxi Province, Ecuador

Country

Ecuador

Period

March-December 2015

Sample size

163 (83 egg, 80 control)

Inclusion and exclusion criteria

not detailed in abstract

4. Methods and endpoints

Exposure / intervention

1 egg per day for 6 months

Comparator

No intervention (both arms received social marketing messages)

Endpoints

Length-for-age and weight-for-age z scores, stunting, underweight, morbidity, dietary intake

Statistical methods

Generalized linear regression; log-binomial models with robust Poisson

5. Actual results

Results

Egg group: length-for-age z +0.63 (95% CI 0.38-0.88); weight-for-age z +0.61 (0.45-0.77); stunting PR 0.53 (0.37-0.77); underweight PR 0.26 (0.10-0.70); reduced intake of sugar-sweetened foods PR 0.71 (0.51-0.97). Caregivers reported no allergic reactions to the eggs.

Absolute risks

not reported in abstract

Authors' conclusion

Early introduction of eggs significantly improved growth in young children.

6. Strengths

  • Randomized design
  • Weekly monitoring of intake and morbidity

7. Weaknesses

  • Not blinded; small sample
  • Single region; larger effect than the later Malawi trial

8. Risk of bias

Orienting tool
RoB 2
Type of assessment
simplified assessment (abstract only)
Full formal assessment
no
Overall risk of bias
some concerns
Rationale

Open-label; outcome measurement by staff; simplified judgement.

9. Assessment of the statistical interpretation

Large effect sizes; the Mazira trial in Malawi (I-EGG-106) did not replicate them, and the WHO pooled analysis of both trials found no significant effect.

10. Relevance to the specific claim

Direct test of daily eggs in infants: no harm and no allergic reactions were reported; growth improved.

11. Independent contrary findings

Malawi trial null for growth (I-EGG-106).

12. Transferability to Germany and Europe

Low-income setting with high stunting; Egypt has relevant child stunting levels (not quantified here).

13. Overall methodological judgement

Shows eggs were well tolerated and beneficial in one setting; not a general proof of growth benefit.

Multidimensional assessment
Multidimensional assessment
Authenticity of the sourceverified
Methodological qualitymoderate
Risk of biassome concerns
Precision of resultsmoderate
Directnessindirect
Reproducibilitynot replicated
Consistency with the overall evidenceinconsistent
Regional transferabilitymoderate
Adequacy of the interpretation (by the archive)not applicable

14. Open questions

Replication across settings.

15. Linked fact checks